IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, M.-L.
Right arrow Articles by Tsao, Y.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, M.-L.
Right arrow Articles by Tsao, Y.-P.
(Investigative Ophthalmology and Visual Science. 2002;43:751-757.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Inducible Adeno-Associated Virus Vector–Delivered Transgene Expression in Corneal Endothelium

Ming-Ling Tsai1,2,3, Show-Li Chen2, Ping-I Chou3, Liang-Yen Wen3, Ray Jui-Fang Tsai4 and Yeou-Ping Tsao1,4

1 From the The Graduate Institute of Medical Science and the 2 Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan; the 3 Department of Ophthalmology, Tri-Service General Hospital, Taipei, Taiwan; and the 4 Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuon, Taiwan.

PURPOSE. To investigate whether recombinant adeno-associated virus (rAAV) vector–mediated transgene expression is induced by inflammation in corneal endothelial cells in vivo.

METHODS. The ocular anterior chamber of New Zealand White rabbits was injected with rAAV-LacZ (107 units of infection). Transient ocular anterior segment inflammation was induced by an intravitreal injection of lipopolysaccharide (LPS). The effect of inflammation on LacZ gene expression in corneal endothelial cells was evaluated by histochemical staining and reverse transcription–polymerase chain reaction (RT-PCR). The influence of rAAV on endothelial cell function was monitored by measuring corneal thickness.

RESULTS. Inflammatory reaction peaked at 1 day after LPS treatment and, at the same time, most of the endothelial cells (91.3% ± 7.2%) showed prominent LacZ gene expression. The transgene expression gradually diminished to basal level (3.4% ± 2.1%) when the inflammation subsided at 15 days after LPS treatment. The diminished transgene expression was efficiently reactivated to a high level (86.1% ± 8.7%) by a second LPS injection 60 days later. Moreover, the transgene expression remained low for a long period (60 days) in the absence of LPS treatment, but was increased to high levels (87.3% ± 8.1%) 1 day after LPS treatment. Throughout the observation period, endothelial cell function remained intact.

CONCLUSIONS. The rAAV vector can deliver genes into endothelial cells, and transgene expression is dramatically induced by inflammation. The rAAV-delivered transgene is stable and does not compromise endothelial cell function. Inducible rAAV-mediated transgene expression in corneal endothelial cells is a potential strategy in the treatment and prevention of ocular diseases.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology